A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas
- Sponsor
- Medical College of Wisconsin
- Study ID
- NCT04745156
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Brain Cancer
- Brain Tumor
- Glioma
- Glioma Intracranial
- Gliomas Benign
- Motor Cortex; Lesion
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- RNS System Implantation — DEVICEFollowing resection consistent with SoC, if there is evidence of residual tumor which cannot be resected due to invasion of hand-M1 but which is small enough to be covered by two four-electrode strips, these strips will be placed on the functional cortex of interest and secured to the dura. The location of the leads will be registered into the navigation software (either Medtronic Stealth or Brainlab). The dura will then be closed as watertight as possible, and the RNS System will be incorporated into the craniotomy on closure Prior to closure, four bone screws will be placed and registered to the intraoperative navigation system as internal fiducials to be retrieved for future procedures.
Study Details
This study uses a cranial implant to deliver cortical stimulation that, when paired with physiotherapy, will remap the brain so that critical brain functions can be protected during brain tumor surgery. This pilot study will provide initial evidence for the safety and feasibility of such a protocol which will lead to future pivotal trials that could radically change eloquent area brain surgery. For patients with otherwise incompletely resectable brain tumors, this could mean a longer life expectancy and a better quality of life.
Key Dates
- First listed
- Feb 9, 2021
- Start date
- Aug 1, 2026
- Status verified
- Jan 2026
- Primary completion
- Aug 31, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 3 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DEVICE_FEASIBILITY
Arms
- Experimental: RNS System ImplantationThis is a device feasibility study, therefore participants will only be enrolled into the investigational arm and will receive the RNS System Implantation.
Primary Outcome Measure
Extent of resection [ Time Frame: Within 1 week after second surgery ]
Central Contacts
- Sarah Cornell414-955-0989
Find similar trials
Related Studies
- Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid TumorsRecruiting · Memorial Sloan Kettering Cancer Center · New York, New York
- Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy ProgramRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)PHASE1/PHASE2 · Recruiting · Plus Therapeutics · Manhasset, New York
- Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor BiomarkerPHASE2 · Recruiting · David W. Roberts · Lebanon, New Hampshire